Genvoya

Genvoya is a combination medication used in the treatment of HIV-1 infection. It contains four active ingredients: emtricitabine, tenofovir alafenamide, cobicistat, and elvitegravir. This oral medication is designed to help manage HIV by reducing the amount of virus in the body.

Genvoya is primarily used for the treatment of HIV-1 infection in adults and children who weigh at least 25 kg. This medication is part of a comprehensive treatment plan that includes other medications and lifestyle changes. Genvoya works by reducing the amount of HIV in the body, which helps to improve immune function and reduce the risk of complications associated with HIV.

Common effects of Genvoya may include headache, nausea, and diarrhea. Some individuals may also experience fatigue, dizziness, or abdominal pain. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Genvoya should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should not be shared with others, even if they have similar symptoms. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Genvoya may interact with other medications, including those used to treat infections, seizures, and heart conditions. It is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also affect the effectiveness of Genvoya, so it is advisable to discuss any dietary changes with your healthcare provider.